Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.56 |
| ▸ | BCR | P11274 | 1/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.56 |
| ▸ | CDK4 | P11802 | 1/20 | 0.54 |
| ▸ | CCND1 | P24385 | 1/20 | 0.54 |
| ▸ | JUN | P05412 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.50 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27992 | 1.00 | TRPA1 (1.00) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL27991 | 1.00 | TRPA1 (1.00) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL3464547 | 1.00 | TRPA1 (1.00) | TRPA1NFKB1CA1CA2CA4 | |
| Potassium SCHEMBL9419818 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL9419834 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL9419828 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL9419830 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL9419814 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| SCHEMBL9419815 | 0.98 | TRPA1 (0.95) | TRPA1NFKB1CA1CA2CA4 | |
| Formaldehyde SCHEMBL20525513 | 0.94 | TRPA1 (0.88) | TRPA1NFKB1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115721587-A | Collagen compound liquid with skin repairing and anti-aging effects | 武汉超爱健康咨询服务有限责任公司 | 2023-03-03 | — | — | CN | claimed |
| CN-121377961-A | 2-Styrylphenol derivative and hypoglycemic effect thereof | 安徽工程大学 | 2026-01-23 | — | — | CN | disclosed |
| WO-2025049901-A1 | STYRYL PHENOL-BASED SURFACTANTS FOR HYDROCARBON RECOVERY | CHEVRON U.S.A. INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20240285548-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF COGNITIVE IMPAIRMENT | NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-3654929-B1 | AQUEOUS COSMETIC COMPOSITION COMPRISING A PYRIDINEDICARBOXYLIC ACID DERIVATIVE AND A HYDROXYSTILBENE | OREAL (FR) | 2024-05-29 | — | — | EP | disclosed |
| EP-3654929-C0 | AQUEOUS COSMETIC COMPOSITION COMPRISING A PYRIDINEDICARBOXYLIC ACID DERIVATIVE AND A HYDROXYSTILBENE | OREAL (FR) | 2024-05-29 | — | — | EP | disclosed |
| CN-115721587-A | Collagen compound liquid with skin repairing and anti-aging effects | 武汉超爱健康咨询服务有限责任公司 | 2023-03-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240285548-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF COGNITIVE IMPAIRMENT | CHAT, COMT, BDNF | TRPA1 4350/4885NFKB1 575/4885CA1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.